CL100-ProliFiler
ProQinase's CL100-ProliFiler is a standard service package comprising IC50 determination of your test compounds on the proliferation response of a defined panel of 100 tumor cell lines.
ProQinase GmbH
ProQinase is a leading contract research organization for drug discovery in oncology. Covering the full range of services from hit identification to proof of concept in animals, ProQinase’s portfolio comprises a broad range of off-the-shelf and customized solutions and together with renowned chemistry partners ProQinase offers Integrated Drug Discovery Services.
Browse Products by Field
ProQinase is a leading contract research organization for drug discovery in oncology. Covering the full range of services from hit identification to proof of concept in animals, ProQinase’s portfolio comprises a broad range of off-the-shelf and customized solutions and together with renowned chemistry partners ProQinase offers Integrated Drug Discovery Services.
ProQinase GmbH was founded in 2001 as a subsidiary of the Tumor Biology Center Freiburg to support in-house anti-cancer drug development. Since 2015 ProQinase belongs to a Chinese private equity fund. The company has about 40 employees and is located in Freiburg in the south-west of Germany.
